Citadel Advisors’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,882,136
| Closed | -$2.41M | – | 6215 |
|
|
2024
Q2 | $2.41M | Sell |
1,882,136
-64
| -0% | -$82 | ﹤0.01% | 2272 |
|
|
2024
Q1 | $5.44M | Sell |
1,882,200
-195,892
| -9% | -$566K | ﹤0.01% | 1694 |
|
|
2023
Q4 | $15.3M | Buy |
2,078,092
+11,721
| +0.6% | +$86.1K | ﹤0.01% | 987 |
|
|
2023
Q3 | $15.9M | Sell |
2,066,371
-5,197
| -0.3% | -$39.9K | ﹤0.01% | 898 |
|
|
2023
Q2 | $21M | Sell |
2,071,568
-33,085
| -2% | -$335K | ﹤0.01% | 795 |
|
|
2023
Q1 | $20.4M | Sell |
2,104,653
-36,844
| -2% | -$358K | ﹤0.01% | 838 |
|
|
2022
Q4 | $10.4M | Sell |
2,141,497
-43,412
| -2% | -$211K | ﹤0.01% | 1284 |
|
|
2022
Q3 | $31.3M | Sell |
2,184,909
-14,300
| -0.7% | -$205K | 0.01% | 587 |
|
|
2022
Q2 | $11.9M | Buy |
2,199,209
+39,777
| +2% | +$215K | ﹤0.01% | 1156 |
|
|
2022
Q1 | $14M | Buy |
2,159,432
+101,330
| +5% | +$656K | ﹤0.01% | 1162 |
|
|
2021
Q4 | $32M | Buy |
2,058,102
+2,643
| +0.1% | +$41.1K | 0.01% | 683 |
|
|
2021
Q3 | $52.4M | Buy |
+2,055,459
| New | +$52.4M | 0.01% | 432 |
|